期刊文献+

脆性组氨酸三联体基因表达在外阴癌诊断中的作用

The Role of Fragile Histidine Triad Gene Expression in the Diagnosis of Vulvar Carcinoma
下载PDF
导出
摘要 目的探索脆性组氨酸三联体基因表达在外阴癌诊断中的作用。方法采用的方法为免疫组化SP法,分别对正常外阴组织25例、外阴上皮内瘤样病变(VINs)29例和外阴癌组织40例实施FHIT蛋白表达的检查。结果正常外阴组织、VINs、外阴癌FHIT蛋白阳性表达率分别为100.0%(25/25),44.8%(13/29),20.0%(8/40),差异有统计学意义(P<0.05)。有淋巴结转移FHIT蛋白阳性表达率为18.2%(2/11),明显低于无淋巴结转移者的27.6%(8/29),差异有统计学意义(P<0.05)。结论 FHIT蛋白的异常表达为诊断外阴癌提供了有力的依据,对外阴癌的治疗与预后提供重要的信息。 Objective To explore the role of fragile histidine triad gene expression in the diagnosis of vulvar carcinoma. MethodsThe method of immunohistochemistry SP was used. The expression of FHIT protein was examined respectively in 25 cases of normal vulvar tissue, 29 cases of intraepithelial neoplasia(VINs) and 40 cases of vulvar carcinoma. Results The positive expression rates of FHIT protein in normal vulvar tissue, VINs and vulvar carcinoma were respectively 100.0%(25/25), 44.8%(13/29), 20.0%(8/40),the difference was statistically significant(P〈0.05). The positive expression rate of FHIT protein with lymph node metastasis was 18.2%(2/11), which was significantly lower than that of those without lymph node metastasis [27.6%(8/29)], and the difference was statistically significant(P〈0.05). Conclusion The abnormal expression of FHIT protein provides a strong basis for the diagnosis of vulva cancer, and provides important information for the treatment and prognosis of external cancer.
作者 王艳 马庆芬 WANG Yah;MA Qing-fen(Shouguang People's Hospital, Shouguang, Shandong, 26270)
机构地区 寿光市人民医院
出处 《智慧健康》 2018年第2期44-45,共2页 Smart Healthcare
关键词 脆性组氨酸三联体 外阴癌 诊断 作用 Fragile histidine triad Vulvar carcinoma Diagnosis Effect
  • 相关文献

参考文献7

二级参考文献78

  • 1史惠蓉,吴庆华,索振河,Jahn M Nesland.宫颈癌组织中FHIT基因5'端CpG岛甲基化及其与基因失活的关系[J].癌症,2005,24(1):7-11. 被引量:20
  • 2任晨春,苗绪红,杨斌,赵磊,孙蕊,宋文芹.宫颈癌患者血浆和组织中FHIT基因5′端CpG岛甲基化状态的研究[J].遗传,2006,28(9):1061-1066. 被引量:12
  • 3Siegel R, Ward E, Brawley 0,et al. Cancer statistics,2011 : the impact of eliminating socioeconomic and racialdisparities on premature cancer deaths [ J ]. CA Cancer JClin, 2011 , 61(4) :212.
  • 4An Q , Liu Y , Gao Y,et al. Detection of pl6 hypermethyl-ation in circulating plasma DNA of non-small cell lungcancer patients [ J ]. Cancer Lett ,2002,188 ( 1/2) : 109.
  • 5Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detec-tion of aberrant promoter hypermethylation of tumor sup-pressor genes in serum DNA from non-small cell lungcancer patients [ J ]. Cancer Res, 1999 ,59 (1) : 67.
  • 6Hoque MO, Begum S, Topaloglu 0,et al. Quantitativedetection of promoter hypermethylation of multiple genes inthe tumor, urine, and serum DNA of patients with renalcancer[ J] . Cancer Res,2004 , 64(15): 5511.
  • 7Crossen PE, Morrison MJ. Methylation status of the 3rd ex-on of the c-MYC oncogene in B-cell malignancies [ J ].Leuk Res, 1999, 23(3) :251.
  • 8Yuille MR, Condie A, Stone EM , et al. TGL1 is activatedby chromosomal rearrangement or by hypomethylation [ J ].Genes Chromosomes Cancer, 2001,30(4) :336.
  • 9Lu L, Katsaros D, de al Longrais IA, et al. Hypermethyla-tion of let-7 a-3 in epithelial ovarian cancer is associatedwith low insulin-like growth factor- II expression and favor-able prognosis[ J]. Cancer Res, 2007 ,67(21) : 10117.
  • 10Hsu HS, Chen TP, Hung CH, et al. Characterization of amultiple epigenetic marker panel for lung cancer detectionand risk assessment in plasma[ J] . Cancer,2007 ,110(9):2019.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部